SCHEMBL20508674

SCHEMBL20508674

Cc1nc2cc(Cl)cnc2n1Cc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 3/20 0.60
TNF P01375 1/20 0.54
ALDH1A1 P00352 4/20 0.53
KDM4E B2RXH2 3/20 0.53
HPGD P15428 3/20 0.53
HSD17B10 Q99714 2/20 0.53
KDM4A O75164 1/20 0.53
TSHR P16473 1/20 0.53
HTT P42858 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
KMT2A Q03164 1/20 0.51
GALR3 O60755 2/20 0.50
NR2F2 P24468 2/20 0.50
RAB9A P51151 1/20 0.50
TBXA2R P21731 2/20 0.49
LMNA P02545 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20508460 0.88 BRD4 (0.49) BRD4TNFALDH1A1KDM4EHPGD
SCHEMBL20508695 0.87 BRD4 (0.47) BRD4TNFALDH1A1KDM4EHPGD
SCHEMBL20508494 0.84 BRD4 (0.45) BRD4ALDH1A1GALR3NR2F2RAB9A
SCHEMBL20508691 0.78 BRD4 (0.43) BRD4ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL12771510 0.77 TNF (0.69) TNFALDH1A1KDM4EHTTKMT2A
SCHEMBL20508532 0.77 KMT2A (0.58) BRD4ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL16489695 0.76 BRD4 (0.56) BRD4ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL16489525 0.76 BRD4 (1.00) BRD4
SCHEMBL1882530 0.75 SMN1; SMN2 (0.62) TNFALDH1A1KDM4EHPGDHSD17B10
SCHEMBL15741934 0.74 TNF (0.61) BRD4TNFALDH1A1KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180273528-A1 IMIDAZO[4,5-b]PYRIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM LES LABORATOIRES SERVIER (FR) 2018-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180273528-A1 IMIDAZO[4,5-b]PYRIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM IDH2, CYP4B1, RB1 BRD4 335/4885TNF 2749/4885ALDH1A1 410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.